Gossamer Bio Inc GOSS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
13.75UNCH (UNCH)
Volume
14,861
Close
13.75quote price arrow down-0.09 (-0.65%)
Volume
640,252
52 week range
5.64 - 14.48
Loading...
  • Open14.06
  • Day High14.29
  • Day Low13.62
  • Prev Close13.84
  • 52 Week High14.48
  • 52 Week High Date08/16/22
  • 52 Week Low5.64
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap1.292B
  • Shares Out93.95M
  • 10 Day Average Volume1.45M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change21.57

KEY STATS

  • Open14.06
  • Day High14.29
  • Day Low13.62
  • Prev Close13.84
  • 52 Week High14.48
  • 52 Week High Date08/16/22
  • 52 Week Low5.64
  • 52 Week Low Date06/16/22
  • Market Cap1.292B
  • Shares Out93.95M
  • 10 Day Average Volume1.45M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change21.57

RATIOS/PROFITABILITY

  • EPS (TTM)-3.05
  • P/E (TTM)-4.51
  • Fwd P/E (NTM)-5.33
  • EBITDA (TTM)-213.665M
  • ROE (TTM)-226.00%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-1,364.10%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gossamer Bio Inc

There is no recent news for this security.

Profile

MORE
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company's product candidates include Seralutinib (GB002), GB004, GB5121 and GB7208. GB002 is an inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R) and c-KIT inhibitor in development for...
Faheem Hasnain
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Bryan Giraudo
Chief Financial Officer, Chief Operating Officer
Caryn Peterson
Executive Vice President - Regulatory Affairs
Christian Waage
Executive Vice President - Technical Operations and Administration
Address
3013 Science Park Rd
San Diego, CA
92121-1101
United States

Top Peers

SYMBOLLASTCHG%CHG
KURA
Kura Oncology Inc
15.50-0.35-2.21%
REPL
Replimune Group Inc
20.42-0.20-0.97%
ACRS
Aclaris Therapeutics Inc
16.47-0.41-2.43%
IGMS
IGM Biosciences Inc
24.35-0.67-2.68%
RYTM
Rhythm Pharmaceuticals Inc
24.16-0.67-2.70%